On May 4, 2026, seven insiders at Seaport Therapeutics, Inc. (SPTX) executed significant share purchases, collectively acquiring approximately $138.60 million worth of stock. Keith Crandell, Robert Nelsen, Steven Gillis, Kristina Burow, Venture Fund Xii, L.P. Arch, Venture Partners Xii, Llc Arch, and Venture Partners Xii, L.P. Arch each purchased 1,100,000 shares at a price of $18.00 per share.
These coordinated purchases represent a substantial commitment from key individuals and entities within Seaport Therapeutics. Cluster insider buying, where multiple insiders buy shares concurrently, is often interpreted as a strong positive signal regarding the company's future prospects.
The total investment across these seven transactions amounted to $19.80 million for each insider, highlighting a unified belief in the company's value by its leadership. Such significant insider acquisitions can be viewed as a bullish indicator by market observers.